Vnitr Lek 2020, 66(7):450-454 | DOI: 10.36290/vnl.2020.127

Screening and brief intervention in illicit drug users

Jana Malinovská1,2, Barbora Švarcová3, Ludmila Brunerová4, Sabina Pálová1, Jan Brož1
1 Interní klinika 2. LF UK a FN Motol, Praha
2 Adiktologická poradna, specializované pracoviště Area fausta, Praha
3 Psychiatrické oddělení, Ústřední vojenská nemocnice - Vojenská fakultní nemocnice, Praha
4 II. interní klinika 3. LF UK a FNKV Praha

Illicit drug use is quite prevalent in the Czech population with a lifetime prevalence of illicit drug use being 29.7 % in 2018. People who use illicit drugs can use health care services more often and they are thus relevant in early identification of illicit substance use disorders and in providing brief intervention. Primary evaluation of presence of illicit substance use disorders can be done using simple and fast screening questionnaires, such as DAST-10. Screening is followed with time effective brief intervention that includes education, advice and motivation for ceasing drug use. Brief intervention should always precede potential referral to specialised addiction services. Implementation of the evidence-based guidelines into daily practise can have a positive effect on early problem resolution, lead to reduction or termination of substance use and decrease harms on patient's health and other areas of his life. Screening of illicit drug use, brief intervention in case of positive screening and eventual referral to a specialist should be implemented into routine medical care.

Keywords: addictive substances, brief intervention, early diagnostics, illicit drugs, screening.

Published: November 3, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malinovská J, Švarcová B, Brunerová L, Pálová S, Brož J. Screening and brief intervention in illicit drug users. Vnitr Lek. 2020;66(7):450-454. doi: 10.36290/vnl.2020.127.
Download citation

References

  1. Pilowsky DJ, Wu LT. Screening for alcohol and drug use disorders among adults in primary care: a review. Subst Abuse Rehabil 2012; 3(1): 25-34. https://doi.org/10.2147/SAR.S30057 Go to original source... Go to PubMed...
  2. D'Amico EJ, Paddock S, Burnam A, Kung, F. Identification of and guidance for problem drinking by general medical providers: results from a national survey. Med Care 2005; 43(3): 229-236. Go to original source... Go to PubMed...
  3. Mravčík V, Chomynová P, Grohmannová K et al. Výroční zpráva o stavu ve věcech drog v České republice v roce 2018. Mravčík V. (Ed.). Praha: Úřad vlády České republiky 2019.
  4. Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey. Drug Alcohol Depend 2008; 97(3): 226-230. https://doi.org/10.1016/j.drugalcdep.2008. 03. 033 Go to original source...
  5. Madras BK, Compton WM, Avula D et al. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend 2009; 99 (1-3): 280-295. https://doi.org/10.1016/j.drugalcdep.2008. 08. 003 Go to original source...
  6. Kabíček P, Sulek Š, Mizerová L et al. Projekt screeningu a krátké intervence v ordinaci praktického lékaře pro děti a dorost vedoucí k snížení zneužívání návykových látek v adolescenci. Čes‑slov Pediat 2010; 65(11): 654-659.
  7. Csémy L, Kabíček P, Dvořáková Z. Krátké intervence pediatra zaměřené na redukci užívání návykových látek u adolescentů. Vox pediatriae 2013; 13(6): 28-30.
  8. Kabíček P, Vacek J, Csémy L. Skrínink a krátká intervence v oblasti návykových látek v praxi praktického lékaře pro děti a dorost. Adiktol prevent léčeb praxi 2019; 2(2): 94-97.
  9. Kurti AN, Keith DR, Noble A et al. Characterizing the intersection of co‑occurring risk factors for illicit drug abuse and dependence in a U.S. nationally representative sample. Prev Med 2016; 92:118-125. doi:10.1016/j.ypmed.2016. 09. 030 Go to original source...
  10. Smith PC, Schmidt SM, Allensworth‑Davies D, Saitz R. A single‑question screening test for drug use in primary care. Arch Intern Med 2010; 170(13): 1155-1160. https://doi.org/10.1001/archinternmed.2010.140 Go to original source... Go to PubMed...
  11. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat 2007; 32: 189-198. Go to original source... Go to PubMed...
  12. Skinner H. The Drug Abuse Screening Test. Addict Behav 1982; 7: 363-371.Další literatura u autorkya na www.casopisvnitrnilekarstvi.cz Go to original source... Go to PubMed...
  13. Miovský M, Čablová L, Jurystová L. Časná diagnostika a krátká intervence v adiktologii. In: K. Kalina et al. Klinická adiktologie. Praha: Grada 2015.
  14. Nešpor K. Krátká intervence a první pomoc pro lidi s návykovými nemocmi. Prakt Lék 2011; 91(8): 489-493.
  15. Aristeiguieta CA. Screening patients for alcohol, tobacco, and other drug misuse: the role of brief interventions. West J Med 2000; 172(1): 53-57. https://doi.org/10.1136/ewjm.172. 1. 53 Go to original source... Go to PubMed...
  16. Frouzová M. Možnosti intervence v oblasti rizikového a problémového užívání drog. In: Csémy L, Čápová E. Prevence rizikového a škodlivého užívání návykových látek a péče o závislé - pro zdravotnické profese. CEPROS, Centrum výzkumu protidrogových služeb a veřejného zdraví, o. p. s. 2013. ISBN 978-80-260-7070-2
  17. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend 2009;99(1-3):280-295. doi:10.1016/j.drugalcdep.2008. 08. 003 Go to original source...
  18. Králíková E, Češka R, Pánková A, et al. Doporučení pro léčbu závislosti na tabáku. Vnitř Lék 2015; 61(Suppl 1): 3-15.
  19. Mattoo SK, Prasad S, Ghosh A. Brief intervention in substance use disorders. Indian J Psychiatry 2018;60(Suppl 4):S466-S472. doi:10.4103/0019-5545.224352 Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.